Charts FibroBiologics, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 16/09/2026 BST			5-day change	1st Jan Change
1.430 ^USD	-0.69%		-18.75%	-68.21%

09-15	FibroBiologics, Inc. announced that it has received $0.500001 million in funding	CI
08-27	FibroBiologics, Inc. Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial	CI

NasdaqUSD

Markets		Quality
Nasdaq	FBLG	Delayed
CBOE	FBLG	Real-time

ProRealTime Chart